Okyo Pharma Limited ADR (OKYO)
1.3200 -0.0700 (-5.04%) 03/26/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 1.4400 +0.1200 (+9.09%) 19:43 ET
for Wed, Mar 26th, 2025
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
03-2021 | |
Cash Flows From Operating Activities | |
Net Income | -3,379 |
Depreciation Amortization | 2 |
Other Working Capital | 1,045 |
Other Operating Activity | 733 |
Operating Cash Flow | $-1,600 |
Cash Flows From Investing Activities | |
PPE Investments | -7 |
Net Acquisitions | -11 |
Investing Cash Flow | $-18 |
Cash Flows From Financing Activities | |
Other Financing Activity | 7,827 |
Financing Cash Flow | $7,827 |
Exchange Rate Effect | 445 |
Beginning Cash Position | 235 |
End Cash Position | 6,889 |
Net Cash Flow | $6,654 |
Free Cash Flow | |
Operating Cash Flow | -1,600 |
Free Cash Flow | -1,600 |